1) Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1-133
https://doi.org/10.1089/thy.2015.0020.
2) Kiess AP, Agrawal N, Brierley JD, Duvvuri U, Ferris RL, Genden E, et al. External-beam radiotherapy for differentiated thyroid cancer locoregional control: A statement of the American Head and Neck Society. Head Neck. 2016;38:493-498
https://doi.org/10.1002/HED.24357.
3) Yi KH, Lee EK, Kang H-C, Koh Y, Kim SW, Kim IJ, et al. 2016 Revised Korean thyroid association management guidelines for patients with thyroid nodules and thyroid cancer. Int J Thyroidol. 2016;9:59-126.
4) Tsang RW, Brierley JD, Simpson WJ, Panzarella T, Gospodarowicz MK, Sutcliffe SB, et al. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Cancer. 1998;82:375-388.
5) Meadows KM, Amdur RJ, Morris CG, Villaret DB, Mazzaferri EL, Mendenhall WM. External beam radiotherapy for differentiated thyroid cancer. Am J Otolaryngol. 2006;27(Supply 9):24-28
https://doi.org/10.1016/J.AMJOTO.2005.05.017.
7) Biermann M, Pixberg MK, Riemann B, Schuck, A, Heinecke, A, Schmid, KW, et al. Clinical outcomes of adjuvant external-beam radiotherapy for differentiated thyroid cancer: Results after 874 patient-years of follow-up in the MSDS-trial. NuklearMedizin. 2009;48:89-98
https://doi.org/10.3413/NUKMED-0221/ID/JR0221-29.
8) Chow SM, Law SCK, Mendenhall WM, AU S-K, Chan PTM, Leung T-W, et al. Papillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapy. Int J Radiat Oncol. 2002;52:784-795
https://doi.org/10.1016/S0360-3016(01)02686-4.
9) Fussey JM, Crunkhorn R, Tedla M, Weickert MO, Mehanna H. External beam radiotherapy in differentiated thyroid carcinoma: A systematic review. Head Neck. 2016;38(Supply 1):E2297-E2305
https://doi.org/10.1002/HED.24218.
10) Chow SM, Yau S, Kwan CK, Poon PCM, Law SCK. Local and regional control in patients with papillary thyroid carcinoma: Specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition. Endocr Relat Cancer. 2006;13:1159-1172
https://doi.org/10.1677/ERC.1.01320.
11) Ford D, Giridharan S, McConkey C, Hartley A, Brammer C, Watkinson JC, et al. External beam radiotherapy in the management of differentiated thyroid cancer. Clin Oncol. 2003;15:337-341
https://doi.org/10.1016/S0936-6555(03)00162-6.
12) Terezakis SA, Lee KS, Ghossein RA, Rivera M, Tuttle RM, Wolden SL, et al. Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-Kettering cancer center experience. Int J Radiat Oncol Biol Phys. 2009;73:795-801
https://doi.org/10.1016/j.ijrobp.2008.05.012.
13) Schwartz DL, Lobo MJ, Ang KK, Morrison WH, Rosenthal DI, Ahamad A, et al. Postoperative external beam radiotherapy for differentiated thyroid cancer: Outcomes and morbidity with conformal treatment. Int J Radiat Oncol Biol Phys. 2009;74:1083-1091
https://doi.org10.1016/j.ijrobp.2008.09.023.